ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3
Eli Lilly and Company (LLY) To Cut Up To 100 Indy Jobs, Send Some Work Overseas
Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture
FDA Grants Genentech (RHHBY)’s Avastin Priority Review For Recurrent Platinum-Resistant Ovarian Cancer
Neogen Corporation (NEOG) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS
Agena Biosciences Appoints Peter Dansky As Chief Executive Officer
Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week
Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO
SAGE Therapeutics Receives Fast Track Designation For Lead Compound SAGE-547 To Treat Status Epilepticus
Cancer Genetics, Inc. (CGIX) Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million
Cerecor Inc. Closes On Initial Tranche Of US $32 Million Series B Financing
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs
Phosphagenics Limited (POH.AX) Completes First Tranche of A $19.3 Million Capital Raising
Baxter International, Inc. (BAX) Initiates Voluntary Worldwide Recall Of Four Lots Of IV Solutions Due To The Presence Of Particulate Matter
Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy
Johnson & Johnson (JNJ) CEO: We Have No Plans To Leave The U.S.
StemCells Inc. (STEM) Announces Closing Of $20 Million Offering
Arno Therapeutics Appoints Alexander Zukiwski, M.D. As Interim Chief Executive Officer And Mr. Lawrence Kenyon As Chief Operating Officer
See All News >
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs
Candid Advice For Cash-Strapped Startups From A Biotech VC
Fall From Grace: BioSpace (DHX) Readers Sound Off On Novartis AG (NVS) And Other Pharma Layoffs
Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy
Johnson & Johnson (JNJ) CEO: We Have No Plans To Leave The U.S.
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions
Anacor Pharmaceuticals, Inc. (ANAC) Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million
Large Allergan Inc. (AGN) Investor Sells Most Of Stake
AbbVie (ABBV) Finally Clinches Shire For $54 Billion
Avid Cyclists Could Have Higher Prostate Cancer Risk, University College London Study
Catalent Pharma Solutions Sees IPO Of 42.5 Million Shares Priced Between $19-$22/Share
Vertex Pharmaceuticals Incorporated (VRTX)'s $300,000 A Year Drug Is Denied, And Medicaid Patients Sue
New Analysis Suggests Pricey Gilead Sciences, Inc. (GILD) Drug Will Bust State Budgets
AstraZeneca PLC (AZN) Unveils Plans For "See-Through" Labs In Cambridge
San Diego Biotech Pfenex Inc. Slashes Proposed Range To $8 A Share, Eyes $65 Million In IPO Debut
Johnson & Johnson (JNJ) Spinout Zosano Pharma, Inc. Sets Terms For $70 Million IPO
Novartis AG (NVS) Plant To Fall Under GlaxoSmithKline (GSK) Control
Vision Loss Associated With Employment Status, JAMA
See All News >
//-->